Chemomab Therapeutics Ltd. American Depositary Share (CMMB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Chemomab Therapeutics Ltd. American Depositary Share, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.10
+4.76% today
Market cap
$8M
Overall quality
60/100
Kronos AI 30-day
+67.9%
8 of 8 simulated paths end higher
Chemomab Therapeutics Ltd. American Depositary Share (CMMB) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $8M. It trades at $1.10, up 4.76% today. Its overall quality score is 60 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +67.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.76 (+67.9%) |
| Likely range | +62.1% … +83.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 92 |
| Growth | 51 |
| Overall | 60 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.